Pages that link to "Q33698419"

The following pages link to Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors (Q33698419):

Displaying 36 items.

• Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. (Q34520190) (← links)
• Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis (Q36089113) (← links)
• Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis (Q36382124) (← links)
• Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study (Q36414326) (← links)
• Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer (Q38388371) (← links)
• Cardiovascular adverse effects of targeted antiangiogenic drugs: mechanisms and management (Q38744149) (← links)
• The safety of new drug treatments for idiopathic pulmonary fibrosis. (Q38929487) (← links)
• Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas (Q38930166) (← links)
• Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity? (Q39040854) (← links)
• Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger? (Q39127820) (← links)
• Metabolic reprogramming in clear cell renal cell carcinoma (Q39290307) (← links)
• Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells (Q42323537) (← links)
• Alpha lipoic acid attenuates radiation-induced oral mucositis in rats (Q42700744) (← links)
• Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report (Q45711840) (← links)
• Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma (Q49953442) (← links)
• Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians (Q50214698) (← links)
• Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer. (Q52601130) (← links)
• Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. (Q52716139) (← links)
• Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. (Q52717006) (← links)
• The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition. (Q53153700) (← links)
• [Side effect management of tyrosine kinase inhibitors in urology : Gastrointestinal side effects]. (Q54196218) (← links)
• Cardiotoxicity with vascular endothelial growth factor inhibitor therapy (Q56991273) (← links)
• Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors (Q57155610) (← links)
• Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors (Q60302337) (← links)
• Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis (Q64109722) (← links)
• Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity (Q64118246) (← links)
• Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 (Q64235204) (← links)
• Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database. (Q64902206) (← links)
• Idiopathic pulmonary fibrosis (Q87721963) (← links)
• A Case Report with Severe Thrombocytopenia Induced by Axitinib (Q89849302) (← links)
• The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study (Q90427159) (← links)
• Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities (Q90480346) (← links)
• Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study (Q91789025) (← links)
• Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance (Q92340667) (← links)
• Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections (Q95819383) (← links)
• An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study (Q97522234) (← links)